A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Han Myint, MD
NextCure, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
- University of Miami
Miami, Florida, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Weill Cornell Medicine
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2023
- Primary completion
- 31 Jan 2025
- Completion
- 31 Jan 2025
- Last update posted
- 28 Jan 2026
- Registered enrollment
- 28
- Registry id
- NCT05787496
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.